ENDRA Life Sciences (NDRA) Inventory (2016 - 2024)

ENDRA Life Sciences (NDRA) has reported Inventory for 9 consecutive years, with $2.7 million the latest figure, recorded in Q3 2024.

• In Q3 2024, Inventory fell 1.66% year-over-year to $2.7 million; the TTM figure through Sep 2024 stood at $2.7 million (down 1.66% YoY), while the FY2023 annual figure was $2.6 million, down 0.83% from the prior year.
• Inventory steadied at $2.7 million in Q3 2024 per NDRA's latest filing, from $2.7 million in the prior quarter.
• Across five years, Inventory topped out at $2.8 million in Q2 2023 and bottomed at $174935.0 in Q1 2020.
• Historically, Inventory has averaged $1.8 million across 5 years, with a median of $2.4 million in 2022.
• Annual changes were most pronounced in 2020 — Inventory jumped 419.75% — and 2024, when it dropped 1.66%.
• ENDRA Life Sciences' Inventory stood at $589620.0 in 2020, then jumped by 117.87% to $1.3 million in 2021, then soared by 105.88% to $2.6 million in 2022, then retreated by 0.83% to $2.6 million in 2023, then gained by 3.4% to $2.7 million in 2024.
• Business Quant data shows NDRA's Inventory at $2.7 million in Q3 2024, $2.7 million in Q2 2024, and $2.7 million in Q1 2024.